These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16956353)

  • 1. Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection.
    Dhar NB; Campbell SC; Zippe CD; Derweesh IH; Reuther AM; Fergany A; Klein EA
    BJU Int; 2006 Dec; 98(6):1172-5. PubMed ID: 16956353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Dhar NB; Jones JS; Reuther AM; Dreicer R; Campbell SC; Sanii K; Klein EA
    BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
    Dhar NB; Klein EA; Reuther AM; Thalmann GN; Madersbacher S; Studer UE
    J Urol; 2008 Mar; 179(3):873-8; discussion 878. PubMed ID: 18221953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.
    Fleischmann A; Thalmann GN; Markwalder R; Studer UE
    J Clin Oncol; 2005 Apr; 23(10):2358-65. PubMed ID: 15800327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.
    Dorin RP; Daneshmand S; Eisenberg MS; Chandrasoma S; Cai J; Miranda G; Nichols PW; Skinner DG; Skinner EC
    Eur Urol; 2011 Nov; 60(5):946-52. PubMed ID: 21802833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K
    Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
    Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
    Zehnder P; Studer UE; Skinner EC; Dorin RP; Cai J; Roth B; Miranda G; Birkhäuser F; Stein J; Burkhard FC; Daneshmand S; Thalmann GN; Gill IS; Skinner DG
    J Urol; 2011 Oct; 186(4):1261-8. PubMed ID: 21849183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of surgically treated bladder carcinoma with extravesical tumor extension.
    Quek ML; Stein JP; Clark PE; Daneshmand S; Miranda G; Cai J; Groshen S; Lieskovsky G; Quinn DI; Raghavan D; Skinner DG
    Cancer; 2003 Sep; 98(5):955-61. PubMed ID: 12942562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy.
    Kassouf W; Leibovici D; Munsell MF; Dinney CP; Grossman HB; Kamat AM
    J Urol; 2006 Jul; 176(1):53-7; discussion 57. PubMed ID: 16753366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
    Jensen JB; Ulhøi BP; Jensen KM
    Int J Urol; 2012 Jan; 19(1):39-47. PubMed ID: 22050425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of extracapsular extension of pelvic lymph node metastasis in patients with bladder cancer treated in the contemporary era.
    Kassouf W; Leibovici D; Luongo T; Munsell MF; Vakar F; Dinney CP; Grossman HB; Kamat AM
    Cancer; 2006 Oct; 107(7):1491-5. PubMed ID: 16894527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.